Verve Therapeutics (VERV) Stock Chart & Stock Price History $5.09 -0.52 (-9.27%) (As of 05:44 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics Stock Price Performance 5 Day Performance-5.25%1 Month Performance+20.22%3 Month Performance-1.81%6 Month Performance+6.08%Year-To-Date Performance-61.19%1 Year Performance-59.99% Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the VERV Stock Chart for Wednesday, December, 18, 2024 VERV Chart by TradingView Verve Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$5.41$5.61+3.70%$5.71$5.231.70 million shs$474.94 million12/16/2024$5.71$5.41-5.25%$5.74$5.191.44 million shs$458.01 million12/13/2024$6.23$5.71-8.35%$6.12$5.451.46 million shs$483.41 million12/12/2024$6.30$6.23-1.11%$6.33$6.03997,641 shs$527.46 million12/11/2024$6.72$6.30-6.25%$6.79$6.06975,520 shs$533.38 million12/10/2024$7.19$6.72-6.54%$7.20$6.641.14 million shs$568.94 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$6.47$7.19+11.13%$7.40$6.521.28 million shs$608.71 million12/06/2024$6.11$6.47+5.89%$6.69$6.08824,553 shs$547.78 million12/05/2024$6.63$6.11-7.84%$6.60$5.971.46 million shs$517.27 million12/04/2024$7.01$6.63-5.42%$7.36$6.582.01 million shs$561.30 million12/03/2024$7.16$7.01-2.09%$7.66$6.913.68 million shs$593.47 million12/02/2024$5.61$7.16+27.63%$7.29$5.594.42 million shs$606.19 million11/29/2024$5.78$5.61-2.94%$5.84$5.56549,045 shs$474.94 million11/28/2024$5.78$5.78$5.87$5.30875,715 shs$489.34 million11/27/2024$5.31$5.78+8.85%$5.87$5.30875,715 shs$489.34 million11/26/2024$5.29$5.31+0.38%$5.36$5.08925,469 shs$449.55 million11/25/2024$4.85$5.29+9.07%$5.48$4.952.56 million shs$447.85 million11/22/2024$4.60$4.85+5.43%$4.87$4.501.13 million shs$410.60 million11/21/2024$4.55$4.60+1.10%$4.69$4.441.38 million shs$389.44 million11/20/2024$4.84$4.55-5.99%$4.84$4.481.45 million shs$385.22 million11/19/2024$4.50$4.84+7.56%$4.93$4.493.17 million shs$409.75 million11/18/2024$4.79$4.50-6.05%$4.92$4.481.91 million shs$380.97 million Related Companies Galapagos Stock Chart Xencor Stock Chart Evotec Stock Chart Arcutis Biotherapeutics Stock Chart Nurix Therapeutics Stock Chart Arcus Biosciences Stock Chart Kiniksa Pharmaceuticals Stock Chart Immunocore Stock Chart Ocular Therapeutix Stock Chart Mesoblast Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts